2000
DOI: 10.1016/s0168-3659(99)00200-x
|View full text |Cite
|
Sign up to set email alerts
|

Polycaprolactone–b-poly(ethylene oxide) copolymer micelles as a delivery vehicle for dihydrotestosterone

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
228
0

Year Published

2001
2001
2016
2016

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 337 publications
(232 citation statements)
references
References 33 publications
4
228
0
Order By: Relevance
“…[9][10][11][12][13][14][15] These block copolymer micelles can be potentially used in specific biological and medical applications. [16][17][18] To obtain different micelle morphologies of block copolymers in solutions, two sets of parameters need to be taken into account. The first set consists of molecular parameters associated with the block copolymer itself, such as the chemical nature (hydrophobicity or hydrophilicity) of the blocks, the block and overall molecular weights, the miscibility of the blocks, and the block copolymer architectures (linear, star, graft, etc.).…”
Section: Introductionmentioning
confidence: 99%
“…[9][10][11][12][13][14][15] These block copolymer micelles can be potentially used in specific biological and medical applications. [16][17][18] To obtain different micelle morphologies of block copolymers in solutions, two sets of parameters need to be taken into account. The first set consists of molecular parameters associated with the block copolymer itself, such as the chemical nature (hydrophobicity or hydrophilicity) of the blocks, the block and overall molecular weights, the miscibility of the blocks, and the block copolymer architectures (linear, star, graft, etc.).…”
Section: Introductionmentioning
confidence: 99%
“…To minimize systemic toxicity due to the large volume of distribution associated with 17-DMAG, safer and more effective delivery of GA relies on the development of biocompatible delivery systems capable of solubilizing the drug and improving its pharmacokinetic properties. The utilization of selfassembled mPEG-b-PCL micelles has been effective at encapsulating other hydrophobic drug molecules for modifying pharmacokinetics and biodistributions [24,25,34]. In addition, there is literature precedence for synthesizing lipophilic prodrugs, such as daunorubicin or 5-fluorouracil, for increasing drug hydrophobicity and enhancing encapsulation into liposomal delivery systems [35][36][37].…”
Section: Discussionmentioning
confidence: 99%
“…The main disadvantage with micellar systems is that unstable micelles can fall apart rapidly in plasma leading to excessive drug loss [22]. However, the utilization of self-assembled diblock micelles of type AB, where A represents the methoxy-capped polyethylene glycol (mPEG) block and B represent the poly(ε-caprolactone) (PCL) block, termed mPEG-b-PCL, has been effective at encapsulating different hydrophobic drug molecules without the inclusion of potentially harmful surfactants and excipients such as CrEL or EtOH [23][24][25]. PCL is an extremely attractive polymer for drug delivery due to the biocompatible nature of the degradation products [26] and PCL is currently approved by the FDA for use in humans.…”
Section: Introductionmentioning
confidence: 99%
“…Overall, they proved to be highly effective drug delivery vehicles [61][62][63][64][65]. To date, most contributions in the area of polymeric micelles for oral formulations, have been made by the group of Kabanov [66][67][68][69][70][71].…”
Section: Polymeric Micellesmentioning
confidence: 99%